Journal of the American Heart Association

Article	Citations
AhR, IRF5, and HO‐1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study	201
Immune Markers, Blood Pressure Severity, and Cardiac Remodeling 1 to 2 Years After Hypertensive Disorders of Pregnancy	182
Level of Perivascular Inflammation Is Significantly Lower Around the Left Internal Mammary Artery Than Around Native Coronary Arteries	171
Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction	168
Understanding Participant Perspectives Toward the Formation of a Participant Advisory Board Within the Reasons for Geographic and Racial Differences in Stroke Study: A National Qualitative Study	168
Inpatient‐Onset Versus Outpatient‐Onset ST‐Segment–Elevation Myocardial Infarction in Patients With Percutaneous Coronary Intervention: A National Registry Study	162
Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020	156
Multi‐Trait Polygenic Risk Score, Nongenetic Determinants, and Cardiovascular Disease Death: A Cohort Study of 14 086 Japanese Individuals	151
Supranormal Ejection Fraction in Heart Failure: Exploring the Heterogeneity of a Distinct Clinical Phenotype	140
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial	138
Early Alteration of Right Ventricle–Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction	135
Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population‐Based Investigation	134
Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice	131
Sociodemographic and Clinical Characteristics and Self‐Care Behaviors Are Associated With Shared Decision‐Making in Adults With Hypertension	128
Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development	123
Cardiovascular Risk Estimation Is Suboptimal in People With HIV	118
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF	116
Recommendations in Extracorporeal Cardiopulmonary Resuscitation Post Resuscitation Care Via An International, Modified Delphi Approach	112
SENP1 Protects Against Pressure Overload‐Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling	108
Neuroprotective Effect of Melatonin in a Neonatal Hypoxia–Ischemia Rat Model Is Regulated by the AMPK/mTOR Pathway	104
Right Ventricular/Pulmonary Artery Coupling in Patients With Heart Failure With Preserved Ejection Fraction: A Clue for Pulmonary Hypertension?	102
Discrimination Between Pre‐ and Postcapillary Pulmonary Hypertension Using Platelet RNA	101
Door‐to‐Needle Time for Extracorporeal Cardiopulmonary Resuscitation and Neurological Outcomes in Out‐of‐Hospital Cardiac Arrest: A Nationwide Study	100
Left Ventricular Ejection Fraction Change Following Percutaneous Coronary Intervention: Correlates and Association With Prognosis	98
Number of Live Births as a Protective Factor Against Clinical and Covert Brain Infarcts: The Framingham Heart Study	97

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry	97
Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J‐PCI Registry	97
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression	96
Association Between Life's Simple 7 and Biomarkers of Cardiovascular Disease: Aldosterone, Interleukin‐6, C‐Reactive Protein	96
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold‐Standard Clinical Models in Multiethnic Populations	94
Racial and Ethnic Disparities in the Medical Management of Poststroke Complications Among Patients With Acute Stroke	91
White Matter Hyperintensities: Complex Predictor of Complex Outcomes	86
Sodium‐Glucose Cotransporter‐2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta‐Analysis of Randomized Trials and Systematic Review	82
Contributions of Women to Cardiovascular Science Over Two Decades: Authorship, Leadership, and Mentorship	80
Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study	79
Myocardial Infarction Across COVID‐19 Pandemic Phases: Insights From the Veterans Health Affairs System	74
Association Between Maternal Factors in Early Pregnancy and Congenital Heart Defects in Offspring: The Japan Environment and Children's Study	74
Prevalence and Management of Multiple Valvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Multicenter Study on the Impact of Staged Valvular Interventions on Outcom	72
Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS	71
Prevalence of Mitral Annulus Disjunction and Mitral Valve Prolapse in Patients With Idiopathic Ventricular Fibrillation	71
Challenges in Assessing Stroke Incidence in Low‐ and Middle‐Income Countries	70
Do Individuals With Inherited Cardiac Diseases Experience Reproductive Decision‐Making Guilt?	69
Reduced Capacity of High‐Density Lipoprotein to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men	69
CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes	69
Clinical Metabolomic Landscape of Cardiovascular Physiology and Disease	68
Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy	66
Editors and Editorial Board	64
Association of Hypertension With Early‐Onset Cryptogenic Ischemic Stroke by the Presence of Patent Foramen Ovale: A Case–Control Study	63
Bench to all Bedsides in Genomics and Precision Medicine	62
Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes t	62
Ultrafast Cooling With Total Liquid Ventilation Mitigates Early Inflammatory Response and Offers Neuroprotection in a Porcine Model of Cardiac Arrest	62
Race, Interleukin‐6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease	62
Correction to: Racial and Ethnic Differences in the Association between Classical Cardiovascular Risk Factors and Common Carotid Intima‐Media Thickness: An Individual Participant Data Meta‐Analysis	62
Correction to: Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease	61
Correction to: Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway	60
Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results	60
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease	60
Correction to: Comparison of Effectiveness Among Different Sodium‐Glucose Cotransporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials	59
Positive Predictive Value of International Classification of Diseases, Ninth Revision, Clinical Modification , and International Classification of Disease	59
Invasive Hemodynamic Predictors of Survival in Patients With Mitral Stenosis Secondary to Mitral Annular Calcification	59
Subendocardial Viability Ratio Is Associated With Target Organ Damage and Hints at a Potential Independent Predictor of Cardiovascular Mortality in Older Adults: A Prospective Cohort Study	59
Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE‐HF	59
Left Ventricular Outflow Tract Morphology as a Predictor of Conductance Disturbances Following Transcatheter Aortic Valve Replacement	59
Contribution of Conventional Cardiovascular Risk Factors to Brain White Matter Hyperintensities	58
Saliva, Plasma, and Multifluid Metabolomic Signatures of Periodontal Disease, Type 2 Diabetes Progression, and Markers of Glycemia and Dyslipidemia Among Puerto Rican Adults With Overweight and Obesit	58
Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST‐Elevation Myocardial Infarction	58
Burden of Hyperlipidemia, Cardiovascular Mortality, and COVID‐19: A Retrospective‐Cohort Analysis of US Data	57
Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy	57
Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients	56
Resource Use Following Revascularization for Multivessel Coronary Artery Disease	56
Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction	56
Factors Influencing Quality Improvement Success in Primary Care: A Comparative Case Study of High‐ and Low‐Performing Sites in Patient Hypertension Outcomes	56
Plasma Multiomics Links Early‐Life Adversity to Disease and Cardiometabolic Health: A Population‐Based Cohort Study	54
Ross Procedure Versus Mechanical Versus Bioprosthetic Aortic Valve Replacement: A Network Meta‐Analysis	54
Trends in Blood Pressure Control During the COVID‐19 Pandemic: A Study of 17 US Health Systems in the National Patient‐Centered Clinical Research Network Blood Pressure Control Laboratory	54

Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries	54
Culprit Lesion Vessel Size and Risk of Reperfusion Injury in ST‐Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study	53
Contributions of Germline and Somatic Mosaic Genetics to Thoracic Aortic Aneurysms in Nonsyndromic Individuals	53
Body Mass Index in Adolescence and Long‐Term Risk of Early Incident Atrial Fibrillation and Subsequent Mortality, Heart Failure, and Ischemic Stroke	53
Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes	53
Right Ventricular–Pulmonary Artery Uncoupling and Strain in Acute Heart Failure	52
Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy	51
Cross‐Sectional Relationships of Proximal Aortic Stiffness and Left Ventricular Diastolic Function in Adults in the Community	51
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry	50
Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction	49
Contemporary Valvular Mechanisms of Aortic Regurgitation in Tricuspid Aortic Valves: Importance in Repair Versus Replacement Strategy	49
Monocyte Chemoattractant Protein‐1, Inflammatory Biomarkers, and Prognosis of Patients With Ischemic Stroke or Transient Ischemic Attack: Fndings From a Nationwide Registry Study	49
Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes	48
Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women	47
Novel Size‐Based High‐Density Lipoprotein Subspecies and Incident Vascular Events	47
Day‐to‐Day Blood Pressure Variability and Risk of Incident Chronic Kidney Disease in a General Japanese Population	47
Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?	47
Randomized, Placebo‐Controlled, Triple‐Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline‐Based Cancer Therapy	47
Comparison of Centers for Disease Control and Prevention and Hospital‐Based Stroke Mortality Data in Kentucky: The Paul Coverdell National Acute Stroke Program	47
Mitophagy in Macrophages: A Metabolic Checkpoint in Inflammation‐to‐Repair Transition in Atherosclerosis	47
Hypertension Severity as Quantified by Hypertension Daily Dose and Blood Pressure With Risk of Stroke in REGARDS	47
Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion	46
Differential Characteristics and Outcomes of Urgent/Emergent Versus Elective Aortic Valve Replacement	46
Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease	46
Unraveling the Complexities for Antiplatelet Strategies Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention	45
Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial	45
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	45
Survival Benefit of Heart–Kidney Versus Heart Transplant With or Without Delayed Kidney Transplant	44
Defining Spiritual Wellbeing in Survivors of Stroke: A Convergent Parallel Mixed Methods Study	44
Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium	44
Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer	43
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance	43
Heart Failure–Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020	43
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure	43
Real‐Time Ambulatory ECG Does Not Expedite Care	43
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction	43
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice	43
Co‐Occurrence of Social Risk Factors and Associated Outcomes in Patients With Heart Failure	43
Metabolic Syndrome and Efficacy of Remote Ischemic Postconditioning in Acute Moderate Ischemic Stroke: A Post Hoc Analysis of the RICAMIS Trial	42
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long‐Term Variability	42
Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program	42
Association Between Pulse Pressure and Structural Brain Changes in Aging: A Systematic Review and Meta‐Analysis of Cross‐Sectional and Longitudinal Studies	42
QRS Fragmentation in Preserved Ejection Fraction Heart Failure: Functional Insights, Pathological Correlates, and Prognosis	42
Left Subclavian Artery Revascularization With In Situ Laser Fenestration During Thoracic Endovascular Aortic Repair for Acute Complicated or High‐Risk Type B Aortic Dissection: Results of the LLTEVAR	42
Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting	42
Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study	41
Multiethnic Perspectives of Shared Decision‐Making in Hypertension: A Mixed‐Methods Study	41
Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid	41
microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery	41
Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis	41
Pyruvate Kinase M2 Protects Heart from Pressure Overload‐Induced Heart Failure by Phosphorylating RAC1	41
Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure	41
Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study	40
Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary Intervention	40
Effect of Combination Antihypertensive Pills on Blood Pressure Control	40
Clinical Outcomes of Diffuse Angiogram‐Negative Subarachnoid Hemorrhage Versus Aneurysmal Subarachnoid Hemorrhage: A Propensity Score‐Matched Analysis	40
A New Clinical Prediction Rule for Infective Endocarditis in Emergency Department Patients With Fever: Definition and First Validation of the CREED Score	40
Quality of Life and Well‐Being in Adults With Fontan Physiology: Findings From the Australian and New Zealand Fontan Registry Quality of Life Study	40
Macrophage Ferroptotic Resistance Is Required for the Progression of Infantile Hemangioma	40
Protective Effect on Spinal Cord Injury of Prophylactic Cerebrospinal Fluid Drainage in Extensive Aortic Arch Repair for Type A Aortic Dissection: A Retrospective Cohort Study	40
Coronary Microvascular Disease Assessed by 82‐Rubidium Positron Emission Tomography Myocardial Perfusion Imaging Is Associated With Small Vessel Disease of the Kidney and Brain	40
Impact of Sex‐ and Gender‐Related Factors on Length of Stay Following Non–ST‐Segment–Elevation Myocardial Infarction: A Multicountry Analysis	40
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial	39
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA‐R Inverse Probability Weighted Analysis	39
Nuclear Receptor Subfamily 4 Group A Member 1 Exacerbates Cardiac Remodeling by Inhibiting Mitochondrial Function Through the Peroxisome Proliferator‐Activated Receptor γ Coactivator‐1α/Nuclear Respir	39
Metabolomic Biomarkers Are Independently Associated With Secondary Adverse Cardiovascular Events in Patients With Coronary Artery Disease	39
Obese Male Mice Exposed to Early Life Stress Display Sympathetic Activation and Hypertension Independent of Circulating Angiotensin II	39
Long‐Term Adherence to Modifiable Factors and Incident Cardiovascular Disease Among Women With a History of Gestational Diabetes: A Prospective Cohort Study	39
Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone	39
Association of Home‐Based Cardiac Rehabilitation With Lower Mortality in Patients With Cardiovascular Disease: Results From the Veterans Health Administration Healthy Heart Program	39
Was COVID‐19 Associated With Worsening Inequities in Stroke Treatment and Outcomes?	38
Alert‐Triggered Patient Education Versus Nurse Feedback for Nonadministered Venous Thromboembolism Prophylaxis Doses: A Cluster‐Randomized Controlled Trial	38
High Self‐Reported Levels of Pain 1 Year After a Myocardial Infarction Are Related to Long‐Term All‐Cause Mortality: A SWEDEHEART Study Including 18 376 Patients	38
Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension	38
Left‐Digit Bias in Serum Creatinine Levels and Contrast Administration: A Nationwide Cohort Study Using a Japanese Percutaneous Coronary Intervention Registry	38
Retinal Microvasculature and Emotional, Behavioral, and Cognitive Outcomes at School Age	38
From Artificial Intelligence to Quantum Computing: Promise and Prudence in the Field of Cardiovascular Medicine	38
Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real‐World Evidence From a Multicenter Cohort Study	38
Association Between Physical Activity Dose and Mental Health Among Stroke Survivors	38
Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity	38

Correction to: Gelatin Methacryloyl Bioadhesive Improves Survival and Reduces Scar Burden in a Mouse Model of Myocardial Infarction	38
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis	38
Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression	38
Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults	38
Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented	38
Yield on Reinterpretation of Genetic Variants in Pediatric Cardiomyopathy	38
Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction	38
Association of Higher Dietary Omega‐3 Fatty Acid Intake With Cardiovascular‐Kidney‐Metabolic Syndrome Stage Severity and Mortality in US Adults: A Cross‐Sectional and Prospective Cohort Analysis of NH	37
Effect of Time Delay on Reperfusion After Tenecteplase in an Extended Time Window: Analysis From the CHABLIS‐T Trials	37
Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention	37
Invasive Strategy With Intended Percutaneous Coronary Intervention Versus Conservative Treatment in Older People With ST‐Segment–Elevation Myocardial Infarction: A Meta‐Analysis	37
Inflammatory Markers and Stroke Outcomes: Lessons From Neutrophil Counts and Antiplatelet Therapy	37
Impact of Left Ventricular Diastolic Pressure Changes on Clinical Outcomes After Transcatheter Aortic Valve Replacement	37
Clinical Outcome Prediction Model in Tetralogy of Fallot Without Pulmonary Valve Replacement Using Contraction Fraction From the SCOUT‐TOF Registry	37
Perioperative Metabolites Are Associated With Adverse Neonatal Congenital Heart Disease Surgical Outcomes	37
Modulation of Abnormal Vasoconstriction Through 2‐Hydroxyisobutyrylation of Tropomyosin 3 Lys141: Targeting Histone Deacetylase 3 as a Key Approach	37
Ninety‐Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Strok	36
Dedicated Versus Conventional Devices in Patients With Pure Native Aortic Regurgitation: A Systematic Review and Meta‐Analysis	36
Within‐Physician Differences in Patient Sharing Between Primary Care Physicians and Cardiologists Who Treat White and Black Patients With Heart Disease	36
Angiographic Microvascular Resistance Is an Independent Predictor of Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement	36
When the Price Is Right: Beyond the Medical Risks and Benefits of Costly Therapies	36
Mediators of Cardiovascular and Renal Outcomes: How Do Novel Diabetes Medications Work?	36
Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure	36
Characterization of “ICU‐30”: A Binary Composite Outcome for Neonates With Critical Congenital Heart Disease	36
Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Systemic Right Ventricles: Incrementally Building the Evidence Base	35
Race and Resuscitation: Taking the Next Steps	35
Cardiogenic Shock Complicating Takotsubo Syndrome: Sex‐Related Differences	35
Age‐Dependent Relationship of Hypertension Subtypes With Incident Heart Failure	35
Impella‐Protected High‐Risk Percutaneous Coronary Intervention in the Elderly: Balancing Feasibility and Necessity	35
Cerebrovascular Disease Detected on Preprocedural Computed Tomography in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement	35
Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study	35
Correction to: Role of Resilience in the Psychological Recovery of Women With Acute Myocardial Infarction	35
Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents	35
Genetic Determinants of Left Atrial Function Are Associated With Stroke	35
CD1d‐Dependent Natural Killer T Cells Mediate Hypertension and Vascular Injury Through Interleukin‐17A	35
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level	34
Interventions in Adults With Repaired Coarctation of the Aorta	34
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States	34
Consensus‐Based Development of a Pediatric Echocardiography Complexity Score: Design, Rationale, and Results of a Quality Improvement Collaborative	34
Influence of the Social Environment on Ideal Cardiovascular Health	34
Single‐Center Experience of Hybrid Pulmonary Valve Replacement Using Left Anterior Thoracotomy With Pulmonary Artery Plication in Patients With Large Right Ventricular Outflow Tract	34
Von Willebrand Factor Antigen Levels Predict Poor Outcomes in Patients With Stroke and Cancer: Findings From the Multicenter, Prospective, Observational SCAN Study	34
Correction to: Long‐Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long‐Term Survival Study (PEARLS)	34
Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic Stroke	34
Impact of Social Vulnerability on Cardiac Arrest Mortality in the United States, 2016 to 2020	34
Real‐World Disparities in Remote Follow‐Up of Cardiac Implantable Electronic Devices and Impact of the COVID‐19 Pandemic: A Single‐Center Experience	34
Circulating Branched Chain Amino Acids and Cardiometabolic Disease	33
Intracranial Atherosclerosis Disease Associated With Cognitive Impairment and Dementia: Systematic Review and Meta‐Analysis	33
Real‐World Evidence Linking the Predicting Risk of Cardiovascular Disease Events Risk Score and Coronary Artery Calcium	33
Inflammation‐Derived and Clinical Indicator‐Based Predictive Model for Ischemic Stroke Recovery	33
Clinical Benefit of Thrombectomy in Large‐Core Infarction Patients Is Mediated by Malignant Cerebral Edema Reduction	33
Asymptomatic Intracerebral Hemorrhage Following Endovascular Stroke Therapy Is Not Benign: A Systematic Review and Meta‐Analysis	33
Long‐Term Clinical‐Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy	33
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease	33
Obstructive Hypertrophic Cardiomyopathy and Takotsubo Syndrome: How to Deal With Left Ventricular Ballooning?	33
Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts	33
Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation	33
Hypoxia Attenuates Pressure Overload‐Induced Heart Failure	33
Genetic‐Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations	33
Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	33
Association Between Triglyceride–Glucose Index and Carotid Plaque Stability in Different Glycemic Status: A Single‐Center Retrospective Study	33
Role of GLP‐1 Receptor Agonists in Managing Cancer Therapy–Related Cardiac Dysfunction	33
Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats	32
Medication Adherence, Blood Pressure Variability, and Mild Cognitive Impairment	32
Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis	32
Congenital Heart Disease, Atrial Fibrillation, and Ischemic Stroke Risk	32
Omega‐3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials	32
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study	32
Effect of Heart Rate on 1‐Year Outcome for Patients With Acute Ischemic Stroke	32
Identifying High‐Risk Cardiac Arrest Neighborhoods Using Social Vulnerability Index and Geospatial Analysis	32
Prevalence of Cerebral Microbleeds and Association With Vascular Risk Factors in a Hispanic and Latino American Cohort	32
Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study	32
Association Between Hypertension and Diabetes Control and COVID‐19 Severity: National Patient‐Centered Clinical Research Network, United States, March 2020 to February 2022	32
How Much Is Too Much? Cardiac Biomarkers After Cardiac Surgery: A Debate With No End in Sight?	32
Reduced Fetuin‐A Levels Are Associated With Exercise Intolerance and Predict the Risk of Adverse Outcomes in Patients With Heart Failure: The Role of Cardiac–Hepatic–Peripheral Interaction	32
Viral Infection and Ischemic Stroke: Emerging Trends and Mechanistic Insights	31
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes	31
County Incarceration Rate and Stroke Death: A Cross‐Sectional Study of the Influence of Physical Environment, Health Care Access, and Community Mental Distress	31
Concomitant Hepatorenal Dysfunction and Malnutrition in Valvular Heart Surgery: Long‐Term Prognostic Implications for Death and Heart Failure	31
Workers’ Activity Profiles Associated With Predicted 10‐Year Cardiovascular Disease Risk	31
SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner	31
BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators	31
Inflammatory Role of Milk Fat Globule–Epidermal Growth Factor VIII in Age‐Associated Arterial Remodeling	31
Patient‐Specific Computational Flow Simulation Reveals Adverse Hemodynamic Factors Associated With Occlusion of Directional Branches After Fenestrated‐Branched Endovascular Aneurysm Repair	31
New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure	31
Prediction of Deterioration of Left Ventricular Function Using 3‐Dimensional Speckle‐Tracking Echocardiography in Patients With Left Bundle‐Branch Block	31
Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease	30
Microglia‐Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction	30
Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial	30
Global Trends and Forecast of Cardiovascular Diseases, Cancer, and Shared Risk Factors: Insights From the GBD 2021	30
Transcatheter Aortic Valve Implantation in Elderly Patients With Aortic Valve Stenosis: The Role of Frailty, Malnutrition, and Sarcopenia	30
Temporal Trend in Revascularization for Patients With Ischemic Cardiomyopathy and Multivessel Coronary Artery Disease	30
Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018	30
Immune Checkpoint Inhibitor Therapy and Acute Coronary Syndrome: A Review of Mechanisms and Management	30
Body Mass Index, Comorbidities, and Ambulatory Care Visits: The REGARDS Study	30